Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10029-2 | GW-5074 | LSM-1029 |  | 5034 | |
| 10026-3 | PD173074 | LSM-1026 |  | 1401 | |
| 10023-3 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 |  | 5291 |
| 10021-5 | Tozasertib | VX680; MK-0457 | LSM-1021 |  | 5494449 |
| 10014-3 | GW843682X | GW843682 | LSM-1014 |  | 9826308 |
| 10013-3 | GSK461364 | GSK461364A | LSM-1013 |  | 15983966 |
| 10008-3 | Sorafenib | BAY-439006 | LSM-1008 |  | 216239 |